| Adult Life after Childhood Cancer in Scandinavia (ALiCCS) |
Childhood Cancer
(All Sites) |
55,000 patients and 275,000 population comparisons |
Up to 60 years |
Jeanette Falck Winther, M.D. |
| Adventist Health Study-2 |
All Sites |
2,000 self-reported; 3,500 incident |
5 |
Gary Fraser. M.D. |
| After Breast Cancer Pooling Project |
Breast |
18,314 |
5 to 11 |
Xiao-Ou Shu, M.D., Ph.D. |
| Antidepressants and Breast Cancer Pharmacoepidemiology (ABC) |
Breast |
28,000 |
Up to 13 |
Reina Haque, Ph.D. |
| American Cancer Society (ACS) Study of Cancer Survivor-I (SCS-I) |
Bladder
Breast
Colon & Rectum
Kidney
Lung & Bronchus
Melanomas of the Skin
Non-Hodgkin Lymphoma
Ovary
Prostate
Uterus |
4,500 |
1, 2, and 9 years post diagnosis |
Kevin Stein, Ph.D. |
| Cancer Genetics Network |
All Sites |
26,000 |
12 |
Dianne Finkelstein, Ph.D. |
| Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE™) |
Prostate |
14,220 |
Variable |
Jenny Broering, R.N., Ph.D. (c), M.P.H. |
| Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE™) Diet and Lifestyle Sub-Study to CaPSURE™ |
Prostate |
1,800 |
Variable |
June Chan, Sc.D. |
| Cancer Research UK Stratified Medicine Programme: Pilot Study |
Breast
Colon & Rectum
Lung & Bronchus
Melanoma Ovary
Prostate |
9,000 |
5 |
stratifiedmedicine@cancer.org.uk
Alice Tuff |
| Cancer Care Outcomes and Research Surveillance Consortium (CanCORS) |
Colon & Rectum
Lung & Bronchus |
10,000 |
7 |
Neeraj Arora, Ph.D.
Jane Weeks, M.D. |
| CGSU Tissue Acquisition and Biorepository Project |
Breast
Lung & Bronchus |
405 |
2 |
Geoffrey Ginsburg, M.D., Ph.D. |
| Childhood Cancer Survivor Study |
Kidney
Leukemias
Non Hodgkin Lymphoma Hodgkin
CNS, Neuroblastoma
Soft-Tissue Sarcoma
Bone Sarcoma |
37,750 |
5 to 35 |
Les Robison, Ph.D.
Greg Armstrong, M.D. |
| ColoCare Cohort (3 study sites) |
Colon & Rectum |
103 (Heidelberg)
150 (Moffitt)
201 (FHCRC)
Recruitment ongoing at all 3 sites |
N/A |
Heidelberg and FHCRC:
Neli Ulrich, Ph.D.
Moffitt:
Erin Siegel, Ph.D., M.P.H. |
| Colon Cancer Family Registry |
Colon |
9,583 colorectal cancer patients
(plus 18,275 relatives and 4,244 population-based controls) |
Up to 14 |
View website for contacts. |
| Commonly Used Medications and Breast Cancer Recurrence |
Breast |
4,400 |
~10 |
Denise Boudreau, Ph.D. |
| Daughter and MothErS Against Breast Cancer (DAMES) |
Breast |
67 |
1 |
Wendy Demark-Wahnefried, Ph.D., R.D. |
| Diet and Lifestyle Sub-Study of the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE™) |
Prostate |
2,134 |
2005 to current
(ongoing) |
June Chan, Sc.D. |
| Genetic Consequences of Cancer Treatment - Danish Part (GCCT) |
All Sites |
31,884 |
Follow-up of offspring in health registries from birth or start of registry till today |
Jeanette Falck Winther, M.D. |
| Genetic Susceptibility of Colorectal Cancer |
Colon & Rectum |
1,553 |
Up to 8 |
Xifeng Wu, M.D., Ph.D. |
| Genetic Susceptibility to Ovarian Cancer |
Ovary |
397 |
10 |
Jie Lin, Ph.D.
Xifeng Wu, M.D., Ph.D. |
| Health, Eating, Activity and Lifestyle (HEAL) Study of Breast Cancer Prognosis |
Breast |
1,180 |
10 |
Anita Ambs |
| Health Professionals Follow-Up Study |
Colon & Rectum
Prostate |
~6,000 prostate cancer cases;
~1,200 colorectal cancer cases |
>22 years |
Walter Willett, M.D., Dr.P.H. |
| Improving the Care and Outcomes of Women Undergoing Breast Surgery |
Breast |
3,083 |
Up to 5 |
Liliana E. Pezzin, Ph.D.
Ann Nattinger, M.D. |
| Iowa Women's Health Study |
All Sites |
11,198 incident cancers since 1986
4,504 alive as of 12/31/2010 |
23 years |
Kim Robien, Ph.D. |
| Leeds Melanoma Cohort and the BioGenoMEL Consortium |
Melanoma |
>2,000 |
N/A |
Julia Newton-Bishop, M.D. |
| LIVESTRONG Survey for People Affected by Cancer |
All Sites |
>4,800 post-treatment survivors and >9,000 people affected by cancer (including family members, friends, and loved-ones) |
Survey every 4 years beginning in 2006 |
Ruth Rechis, Ph.D.
Stephanie Nutt |
| Lung Cancer Survival |
Lung & Bronchus |
>500 |
0-12 |
Raphael Bueno, M.D. |
| Mayo Clinic Ovarian Cancer Study |
Ovary |
~900 |
11 |
Ellen Goode, Ph.D. |
| Myelodysplastic Syndrome/Acute Myeloid Leukemia Follow-Up Study |
Leukemias |
2,200 |
6 |
Sara Strom, Ph.D. |
| Molecular Characteristics of Early Stage Breast Cancer |
Breast |
~2,400 |
10 to 25 |
Melissa Bondy, Ph.D. |
| Molecular Epidemiology of Non-Hodgkin Lymphoma Survival |
Non-Hodgkin Lymphoma
(including CLL) |
>4,500 |
Median for living patients: 3 yrs
(max.: 9 years) |
James R. Cerhan, M.D., Ph.D. |
| Molecular Predictors of Risk and Clinical Outcomes in Patients with Bladder Cancer |
Bladder |
2,401 |
Up to 14 |
Xifeng Wu, M.D., Ph.D. |
| Multiethnic Cohort Study |
All Sites |
12,000 |
Up to 15 |
Laurence Kolonel, M.D., Ph.D. |
| National Wilms Tumor Late Effects Study |
Kidney
(Wilms Tumor) |
9,236 with 7,681 alive |
14.7 |
Norman Breslow, Ph.D. |
| Nurses' Health Study I and Nurses' Health Study II |
Bladder
Breast
Colon & Rectum
Kidney
Leukemias
Liver
Lung & Bronchus
Melanomas of the Skin
Non-Hodgkin Lymphoma
Oral Cavity & Pharynx
Ovary
Pancreas
Prostate
Stomach
Thyroid
Uterus
|
9,200 invasive breast cancer in NHS and 2,600 in NHS II (as of 2008) |
Vary and depend upon years of diagnosis |
Wendy Chen, M.D., M.P.H.
Michelle Holmes, M.D., Dr.P.H. |
| Environment and Genetics in Lung Cancer Etiology (EAGLE) |
Lung
Bronchus |
2,000 patients
400 survivors |
>5 |
Maria Teresa Landi, M.D., Ph.D. |
| Population Sciences Biorepository |
Breast
Colon & Rectum
Liver
Lung & Bronchus
Pancreas
Stomach
|
734 |
2 |
Michael Scheurer, Ph.D. |
| Promoting Health in Prostate and Breast Cancer Survivors |
Prostate
Breast |
543 |
2 |
Wendy Demark-Wahnefried, Ph.D., R.D. |
| Prostate Cancer Active Surveillance Study (PASS) |
Prostate |
~600 to date, goal is 1000 |
2007-current |
Lisa Newcomb, Ph.D.
June Chan, Sc.D. |
| Prostate Cancer: Effects of Flax Seed Supplementation and Dietary Fat Restriction |
Prostate |
161 |
1 |
Wendy Demark-Wahnefried, Ph.D., R.D. |
| Prostate Cancer Follow-Up Cohort |
Prostate |
1,200 |
12 |
Sara Strom, Ph.D. |
| Prostate Cancer Outcomes Study |
Prostate |
3,500 |
13 |
Linda Harlan, Ph.D.
David Penson, M.D., M.P.H. |
| Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
All Sites |
22,300 |
13 |
Amanda Black, Ph.D., M.P.H.
Wen-Yi Huang, Ph.D., M.S.P.H. |
| Rare Cancer Genetics Registry |
Kidney
Leukemias
Oral Cavity & Pharynx
Pancreas
Stomach
Other Rare Cancers
|
600 |
1 |
Dianne Finkelstein, Ph.D. |
| Reaching-out to ENhancE Wellness in Cancer Survivors (RENEW) |
Breast
Colon & Rectum
Prostate |
641 |
7 |
Wendy Demark-Wahnefried, Ph.D., R.D. |
| SNPs to Risk of Metastasis (SToRM) |
Metastatic Breast |
1,000 |
N/A |
David Cox, M.S., Ph.D. |
| Southern Community Cancer Survivorship Study |
Breast |
577 |
N/A |
Ann Marie Flores |
| St. Jude Lifetime Cohort |
Cancers diagnosed under age 21 |
>4,000 |
10 to 48 |
Melissa Hudson, M.D.
James Gurney, Ph.D. |
| Survivor Training for ENhancinG Total Health (STRENGTH) |
Breast |
90 |
1 |
Wendy Demark-Wahnefried, Ph.D., R.D. |
| Total Cancer Care |
All Sites |
>72,000 |
Up to 5 |
View website for contacts. |
| University of North Carolina (UNC) Health Registry/Cancer Survivorship Cohort |
Bladder
Breast
Colon & Rectum
Kidney
Liver
Pancreas
Prostate
Stomach |
500 through 9/2011
(target goal: 10,000) |
Currently enrolling patients |
Jeannette Bensen, Ph.D., M.S.
Debra Irwin, Ph.D., M.S.P.H. |
| Urologic Oncology Database (UODB) - Bladder Cancer |
Bladder |
730 through 10/2011 |
1997-current |
Janet Cowan, R.N., Ph.D. (c), M.P.H. |
| University of California, San Francisco (UCSF) Urologic Oncology Database and Tissue Bank |
Prostate |
~3,000 with tissue and clinical data |
2000-current |
June Chan, Sc.D.
Janet Cowan
Matt Cooperberg, M.D., M.P.H. |
| VITamins And Lifestyle (VITAL) Cohort Study |
All Sites |
10,000 |
0 to 10 |
Emily White, Ph.D. |
| Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study |
Breast |
2,100 (another 2,000 being enrolled) |
1985 to 2011 |
Jonine Bernstein, Ph.D. |
| Women's Healthy Eating and Living (WHEL) Study * |
Breast |
3,088 |
7.3 |
Shirley Flatt |
